Financial Times Novo Nordisk weight-loss drug wins US approval as a daily pill
Danish company will be first to market with oral obesity treatment but rival Eli Lilly is not far behind
Danish company will be first to market with oral obesity treatment but rival Eli Lilly is not far behind